<!--#if expr="$title" --> <!--#echo var="title" --> <!--#else --> HIV Drug Resistance Database <!--#endif -->
Stanford University HIV Drug Resistance Database - A curated public database designed to represent, store, and analyze the divergent forms of data underlying HIV drug resistance.

Isolate Data

Patient Isolate Region Year Species Subtype Source Clone Method
3313 3313_3 U.S. 2011 HIV1 B Plasma None

Treatment History
Order Regimen Weeks
1 None 52
2 EVG 81

Integrase Sequence
INIMajorDRMs INIMinorDRMs Polys UnusualMuts
    K7KR, E11D, D25DE, F26FY, P90PS, L101I, K111R, S119P, T122I, T124A, M154L, D256E  
>3313_3| codons 1-288
FLDGIDRAQEDHEKYHSNWRAMASEYNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGI
WQLDCTHLEGKIILVAVHVASGYIEAEVISAETGQETAYFILKLAGRWPVRTIHTDNGPN
FISATVKAACWWAGIKQEFGIPYNPQSQGVVESLNKELKKIIGQVRDQAEHLKTAVQMAV
FIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRDPLWKGPAK
LLWKGEGAVVIQDNSEIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED

References
Author Title Citation
Molina, JM Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study. Lancet Infect Dis, 2012